newsfilter
← Latest News
Business Wire·

Atara Biotherapeutics Provides a Business Update

Atara renegotiates one-time milestone payment with HCRx Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop